SCHEMBL18156731

SCHEMBL18156731

c1ccc(-n2c(-c3ccc(-c4ccc5oc6c7c(ccc6c5c4)C4(c5ccccc5-c5ccccc54)c4ccccc4-7)cc3)nc3ccccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.38
ESR2 Q92731 3/20 0.38
RECQL P46063 1/20 0.36
PRKACA P17612 1/20 0.36
RPS6KB1 P23443 1/20 0.36
GSK3B P49841 1/20 0.36
ROCK1 Q13464 1/20 0.36
GRIA1 P42261 1/20 0.36
CACNG8 Q8WXS5 1/20 0.36
CACNG2 Q9Y698 1/20 0.36
PTGS2 P35354 1/20 0.33
PTGER4 P35408 1/20 0.33
HTT P42858 2/20 0.33
MAPK1 P28482 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
MEN1 O00255 1/20 0.32
HSP90AA1 P07900 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156738 0.97 ESR1 (0.42) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL18156735 0.96 RECQL (0.38) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL18156732 0.94 ESR1 (0.39) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL18156833 0.92 ESR1 (0.36) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL18156829 0.91 ESR1 (0.42) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL16855612 0.90 ESR1 (0.40) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL18156736 0.90 ESR1 (0.40) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL18156764 0.89 ESR1 (0.39) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL16855494 0.89 RECQL (0.36) ESR1ESR2RECQLPRKACARPS6KB1
SCHEMBL20224309 0.88 RECQL (0.35) ESR1ESR2RECQLPRKACARPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-11545634-B2 Heterocyclic spiro compounds MERCK PATENT GMBH (DE) 2023-01-03 US disclosed
EP-3708634-A1 HETEROCYCLIC SPIRO COMPOUNDS Merck Patent GmbH (DE) 2020-09-16 EP disclosed
US-10777750-B2 Heterocyclic spiro compounds BASF SE (DE) 2020-09-15 US disclosed
US-20200266364-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-08-20 US disclosed
EP-3083880-B1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2020-04-01 EP disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 ESR1 107/4885ESR2 130/4885RECQL 1091/4885
US-11545634-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 ESR1 107/4885ESR2 130/4885RECQL 1091/4885
US-20200266364-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 ESR1 107/4885ESR2 130/4885RECQL 1091/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 ESR1 107/4885ESR2 130/4885RECQL 1091/4885
US-10777750-B2 Heterocyclic spiro compounds NES, KCNC1, HCN4 ESR1 107/4885ESR2 130/4885RECQL 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.